Skip to main content

Table 2 Mean/median QoL scores at baseline, month 3 and month 6 visits

From: Quality of life in patients treated with first-line antiretroviral therapy containing nevirapine or efavirenz in Uganda: a prospective non-randomized study

QoL summary score

Baseline visit

Month 3 visit

Month 6 visit

Change from baseline to month 6 (SD/correlation) p value

Mean (SD) or median (IQR)

Mean (SD) or median (IQR)

Mean (SD) or median (IQR)

PHS

46.5 (4.6)

47.1 (3.9)

47.3 (3.8)

0.8 (5.0)

p = 0.0036

MHS

46.4 (4.5)

47.4 (3.5)

47.2 (3.3)

0.8 (4.8)

p = 0.0002

GPGI

71.7 (55, 85)

71.67 (57, 85)

73.3 (60,87)

r = 0.35

p < 0.001